Stempoint Capital as of Sept. 30, 2024
Portfolio Holdings for Stempoint Capital
Stempoint Capital holds 50 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals (SNDX) | 10.9 | $38M | 2.0M | 19.25 | |
| Roivant Sciences SHS (ROIV) | 9.2 | $32M | 2.8M | 11.54 | |
| Immunovant (IMVT) | 7.2 | $25M | 871k | 28.51 | |
| Merus N V (MRUS) | 6.1 | $21M | 421k | 49.96 | |
| Arcutis Biotherapeutics (ARQT) | 5.4 | $19M | 2.0M | 9.30 | |
| Amicus Therapeutics (FOLD) | 4.6 | $16M | 1.5M | 10.68 | |
| Applied Therapeutics (APLT) | 4.4 | $15M | 1.8M | 8.50 | |
| Bristol Myers Squibb (BMY) | 4.1 | $14M | 275k | 51.74 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.2 | $11M | 214k | 51.10 | |
| Biohaven (BHVN) | 3.1 | $11M | 216k | 49.97 | |
| Praxis Precision Medicines I Com New (PRAX) | 2.9 | $10M | 174k | 57.54 | |
| Autolus Therapeutics Spon Ads (AUTL) | 2.7 | $9.5M | 2.6M | 3.63 | |
| Incyte Corporation (INCY) | 2.5 | $8.6M | 130k | 66.10 | |
| Denali Therapeutics (DNLI) | 2.4 | $8.2M | 282k | 29.13 | |
| Day One Biopharmaceuticals I (DAWN) | 2.0 | $7.1M | 507k | 13.93 | |
| Acelyrin (SLRN) | 1.9 | $6.5M | 1.3M | 4.93 | |
| Soleno Therapeutics (SLNO) | 1.8 | $6.2M | 123k | 50.49 | |
| Cabaletta Bio (CABA) | 1.7 | $6.0M | 1.3M | 4.72 | |
| Immatics SHS (IMTX) | 1.5 | $5.1M | 450k | 11.41 | |
| Keros Therapeutics (KROS) | 1.5 | $5.0M | 87k | 58.07 | |
| Arcellx Common Stock (ACLX) | 1.4 | $5.0M | 60k | 83.51 | |
| Nurix Therapeutics (NRIX) | 1.3 | $4.6M | 203k | 22.47 | |
| Tscan Therapeutics (TCRX) | 1.2 | $4.3M | 861k | 4.98 | |
| Zura Bio Class A Ord Shs (ZURA) | 1.2 | $4.2M | 1.0M | 4.06 | |
| Ideaya Biosciences (IDYA) | 1.2 | $4.2M | 133k | 31.68 | |
| Terns Pharmaceuticals (TERN) | 1.1 | $3.7M | 449k | 8.34 | |
| Vistagen Therapeutics Ord (VTGN) | 1.0 | $3.6M | 1.8M | 1.94 | |
| Perspective Therapeutics Com New (CATX) | 0.9 | $3.2M | 238k | 13.35 | |
| Pyxis Oncology Common Stock (PYXS) | 0.9 | $3.1M | 850k | 3.67 | |
| Neurogene (NGNE) | 0.9 | $3.1M | 73k | 41.96 | |
| Urogen Pharma (URGN) | 0.9 | $3.1M | 242k | 12.70 | |
| Vigil Neuroscience (VIGL) | 0.7 | $2.5M | 744k | 3.40 | |
| Wave Life Sciences SHS (WVE) | 0.7 | $2.5M | 300k | 8.20 | |
| Bridgebio Pharma (BBIO) | 0.7 | $2.4M | 95k | 25.46 | |
| Janux Therapeutics (JANX) | 0.6 | $2.2M | 49k | 45.43 | |
| Surrozen Com New (SRZN) | 0.6 | $2.2M | 183k | 11.98 | |
| Rhythm Pharmaceuticals (RYTM) | 0.6 | $2.2M | 41k | 52.39 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.6 | $2.1M | 200k | 10.45 | |
| Sarepta Therapeutics (SRPT) | 0.5 | $1.9M | 15k | 124.89 | |
| Protara Therapeutics Com Stk (TARA) | 0.5 | $1.7M | 943k | 1.83 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.4 | $1.5M | 150k | 10.02 | |
| Tourmaline Bio (TRML) | 0.4 | $1.4M | 56k | 25.71 | |
| Capricor Therapeutics Com New (CAPR) | 0.4 | $1.4M | 94k | 15.21 | |
| Alkermes SHS (ALKS) | 0.4 | $1.4M | 49k | 27.99 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $1.3M | 84k | 15.99 | |
| Mbx Biosciences | 0.4 | $1.3M | 50k | 25.98 | |
| Cytokinetics Com New (CYTK) | 0.2 | $764k | 15k | 52.80 | |
| Revolution Medicines (RVMD) | 0.2 | $755k | 17k | 45.35 | |
| Astria Therapeutics (ATXS) | 0.2 | $619k | 56k | 10.99 | |
| Edgewise Therapeutics (EWTX) | 0.2 | $531k | 20k | 26.69 |
